Kezdőlap
Mélykutatási eredmények
QA
Jelek
Területek
Módszertan
Névjegy
Keresés
Kutatási jelek – Signal Engine
BONES Study: Evaluation and Staging
— Osteosarcoma
UCSD Head and Neck Squamous Cell Carcinoma Trial: BCA101 Monotherapy and in Combination Therapy in Patients With EGFR‑driven Advanced Solid Tumors
— Head and neck squamous cell carcinoma
DLBCL: Diffuse Large B-Cell Lymphoma
— Diffuse large B-cell lymphoma
A Phase 2 Study of Docetaxel and Capecitabine in Advanced Squamous Cell Carcinoma of the Head and Neck
— Head and neck squamous cell carcinoma
Real-world treatment patterns in ES‑SCLC highlight continued unmet medical need in the era of new therapies: ESSENCE Study
— SCLC
Promising Advances in Pancreatic Cancer: ASCO 2025 Highlights
— Pancreatic cancer
Zanubrutinib Plus Venetoclax Effective in Patients With CLL/SLL Regardless of Del(17p)/TP53 Mutation
— Chronic lymphocytic leukemia
Durvalumab Receives Priority Review for Gastric/GEJ Cancers
— Hepatocellular carcinoma
Duke Cancer Institute Announces New Thyroid Cancer Center
— Thyroid cancer
Immunotherapy for leukemia may change the bone marrow environment, cancer researchers find
— Leukemia
Scientists use zebrafish to study how Merkel cells develop
— Merkel cell carcinoma
Design and rationale of the phase II PANDORA trial: first line chemo‑immunotherapy in advanced Merkel cell carcinoma
— Merkel cell carcinoma
Study uncovers how prostate cancer becomes deadly, offers hope for new treatments
— Prostate cancer
New diagnostic breakthrough predicts which head and neck cancer patients can be cured with surgery alone
— Head and neck squamous cell carcinoma
Emerging therapies in Ewing sarcoma
— Ewing sarcoma
Yale Head and Neck Cancer SPORE
— Head and neck squamous cell carcinoma
Real-World Lurbinectedin Exhibits Safety and Modest Efficacy in ES‑SCLC
— SCLC
Actuate Therapeutics Advances Clinical Program in Ewing Sarcoma After Positive Phase 1 Trial Demonstrates Complete and Partial Responses in Difficult-to-Treat Pediatric Sarcomas
— Ewing sarcoma
New Insights Into Ovarian Cancer: Why Whole-Genome Doubling May Hold the Key to Future HGSOC Treatment Strategies
— Ovarian cancer
ASCO Update to Pleural Mesothelioma Treatment Guidelines
— Malignant pleural mesothelioma
Előző
40/102
Következő